◆ 会议时间:2025年10月9-11日
◆ 会议地点:意大利 佛罗伦萨
◆ 会议简介:
2025年第28届视觉与眼科研究协会(EVER)年会/大会将于2025年10月9-11日在意大利佛罗伦萨举行。
欧洲视觉和眼科研究协会(EVER)是一个非营利性的国际组织,是欧洲领先的涵盖眼科和视觉科学各个方面的眼科研究协会,其宗旨是通过会议、出版物和信息交流宣等,支持有关眼科和视觉方面知识的研究和传播。EVER现在全球48个国家拥有850余名成员,代表11个科学部门,从流行病学到光学,角膜到视网膜,以及免疫学到遗传学等等。EVER的主要活动之一是每年秋季举办一次高质量的研究会议,每年都有来自世界各地的专业人士出席大会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
EVER 2025 - 28th Congress of the European Association for Vision and Eye Research (EVER)
Dates: 9-11 October 2025
Venue: Florence, Italy
以下为上届信息
摘要征文投稿:
- Abstract submission opening: 2 April 2024
- Abstract submission deadline: 30 May 2024 - NEW 10 JUNE
- Notification of abstract acceptance: 3 July 2024 - NEW 9 JULY
- Early bird registration deadline: 1 August 2024
点此提交摘要>>>Submit Abstract>>>
Presentations Type:
- Poster
- Rapid fire (oral, 4 minutes), selected by the Scientific Committee from poster submissions
- Free papers (oral, 12 minutes
Only research studies (basic, translational or clinical) with results are eligible for oral presentation formats (Rapid Fire or Free Papers).
Clinical cases are limited to poster presentations
You must select your presentation type preference from one of the following options:
An option for Free Paper only is not available.
- #1 Poster (first choice), #2 Free Paper (second choice)
- #1 Free Paper (first choice), #2 Poster (second choice)
- Poster only
Please note that all submitted abstracts will be peer reviewed by the Scientific Committee and their selection will be final within:
- Poster
- Poster and rapid fire
- Free paper, without poster presentation
Evaluation Criteria: Submissions will be rated on a scale of 0 to 10 across six categories: Clarity, Interest and Originality, Hypothesis and Objectives, Material and Methods, Results, and Conclusions. The maximum score will be 60. Submissions with a score below 30 will be rejected.
Please carefully follow the instructions before submitting the abstract. Submissions incomplete or not compliant with the instructions will be refused. The abstract will be online for review by the author until the final submission deadline. The submission is only possible on-line. Abstracts submitted by e-mail, fax or post will not be accepted.
- The presenting author must be the First Author, the individual whose name appears first on the abstract. An abstract must be submitted with the intention that, if accepted, it will be presented by the First Author.
- The abstract must be clear, concise and written in English. Please be aware that abstracts submitted in languages other than English will not be accepted. The abstract will be published and submitted; presenters are requested to carefully proofread their abstract.
- Abstract length is limited to 2000 characters including spaces. If possible, please avoid including pictures and tables.
- Abstract body should be structured as follows: References (if any), Aims / Purpose, Methods, Results, Conclusions. Please download and use the template available on the submission page.
- Non-conventional abbreviations are not allowed in the title, that must be in English as well. If abbreviations are used in the text, please write the full description when first used.
- When submitting the abstract, authors are invited to select a specific congress topic (only one) from the following list:
- ACB: Anatomy / Cell Biology
- COS: Cornea / Ocular Surface
- EOVS: Electrophysiology / Physiological Optics / Vision Sciences
- G: Glaucoma
- IM: Immunology / Microbiology
- LC: Lens and Cataract
- MBGE: Molecular Biology / Genetics / Epidemiology
- NSPH: Neuro-ophthalmology / Strabismology / Paediatric / History
- PBP: Physiology / Biochemistry / Pharmacology
- PO: Pathology / Oncology
- RV: Retina / Vitreous
- Each Presenter can present up to two abstracts.
- Presenting authors who are under 35 years of age at the time of the abstract submission are eligible for the YOUNG INVESTIGATOR AWARD.
- Presenting authors who are under 35 years of age at the time of abstract submission and from inclusiveness target countries and/or low or middle income countries may apply for a travel grant (see here list of eligible countries)
- The abstract ideally should be newly presented data but can include data presented within 6 months and not already published at the time of submission.
- All accepted abstracts will be published on EVER Congress website and on Acta Ophthalmologica online journal.
注册费:
Registration fees are in Euro (VAT included). Registration fees will be adjusted according to VAT charge alignment.
REGISTRATION FEES |
EARLY
Within 1 August
2024 |
STANDARDFrom 2 August
till 3 October 2024 |
LATEFrom 4 October 2024
and on-site |
Member * |
€ 365,00 |
€ 425,00 |
€ 490,00 |
Non-Member |
€ 650,00 |
€ 700,00 |
€ 775,00 |
Attendees in training** / Young attendees (Under 35) *** |
€ 165,00 |
€ 225,00 |
€ 275,00 |
Industry (Sponsors)**** |
€ 365,00 |
€ 365,00 |
€ 365,00 |
Industry (Professionals)***** |
€ 880,00 |
€ 880,00 |
€ 880,00 |
* Reduced registration fee for EVER members. To benefit from the discount, you will need to become an EVER member before registering. Membership status will be verified by EVER. Be aware if your membership is not updated, the “Non member fee” will be applied.
** Status of Attendee in training should be certified by a letter from the head of the department stating that the applicant is an ophthalmology resident or a PhD or Master Student at the time of registration.
*** Copy of valid document (ID or passport) to certify the date of birth is mandatory to be up-loaded in the on-line platform directly (pdf format is required).
**** Corporate personnel of companies that support the event with a sponsorship (not exhibiting companies)
***** Commercial representatives and corporate personnel who have a legitimate educational or business reason for attending, but do not have a sponsorship or product and service to exhibit.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|